The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prediction of 10yr distant recurrence (DR) using the Prosigna (PAM50) assay in a Danish Breast Cancer Cooperative Group (DBCG) cohort of postmenopausal Danish women with hormone receptor-positive (HR+) early breast cancer (EBC) allocated to 5yr of endocrine therapy (ET) alone.
 
Anne-Vibeke Lænkholm
Consulting or Advisory Role - DAKO; Roche Pharma AG
Travel, Accommodations, Expenses - Roche Pharma AG
 
Maj-Britt Jensen
Travel, Accommodations, Expenses - Novartis
 
Jens Ole Eriksen
Patents, Royalties, Other Intellectual Property - Herlev Hospital; Region Zealand Hospital
 
Torben Kibøll
No Relationships to Disclose
 
Birgitte Bruun Rasmussen
Stock and Other Ownership Interests - Coloplast; Novo Nordisk
Consulting or Advisory Role - DAKO
 
Ann S. Knoop
No Relationships to Disclose
 
Sean Ferree
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
Patents, Royalties, Other Intellectual Property - NanoString Technologies
 
Taryn Haffner
Employment - NanoString Technologies
 
Carl Schaper
Consulting or Advisory Role - Accelerated Medical Diagnostics; AcroMetrix; Cesca Therapeutics; DiaDexus; Epigenomics; Lab21; NanoString Technologies; Siemens; Verax Biomedical
 
Bent Ejlertsen
Research Funding - Amgen; NanoString Technologies; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Roche Pharma AG